Caris Life Sciences, Inc. (CAI)

Caris Life Sciences Revenue

Caris Life Sciences had revenue of $263.71M in the quarter ending June 30, 2026, with 45.38% growth. This brings the company's total for the last twelve months to $989.61M, up 85.37% year-over-year. In the year 2025, Caris Life Sciences had annual revenue of $812.03M with 96.97% growth. That makes Caris Life Sciences the 7,687th largest company in the world by revenue and 1,801st in the United States.

• Revenue (ttm): $989.61M
• Revenue Growth: +85.37%
• P/S Ratio: 9.80
• Revenue / Employee: $536,081
• Employees: 1,846
• Market Cap: 9.70B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Molecular Profiling Services 766.72M 94.4%
• Pharma Research and Development Services 45.31M 5.6%

By Geography

Chart

• United States 801.39M 98.7%
• International 10.64M 1.3%

Fiscal year ended Dec 31, 2025 See the full Caris Life Sciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	812.03M	399.77M	96.97%
Dec 31, 2024	412.26M	106.13M	34.67%
Dec 31, 2023	306.13M	47.64M	18.43%
Dec 31, 2022	258.49M	-	-

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Aug 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error